|
|
||||||||




* Allergy and Clinical Immunology, National Heart and Lung Institute, and
Leukocyte Biology, Biomedical Sciences Division, Faculty of Medicine, Imperial College, London, United Kingdom; and
Millennium Pharmaceuticals, Inc., Cambridge, MA 02139
Eotaxin and eotaxin-2, acting through CCR3, are potent eosinophil chemoattractants both in vitro and in animal models. In this study we examined the capacity of eotaxin and eotaxin-2 to recruit eosinophils and other inflammatory cells in vivo in human atopic and nonatopic skin. Skin biopsies taken after intradermal injection of eotaxin and eotaxin-2 were examined by immunohistochemistry. Allergen- and diluent-challenged sites were used as positive and negative controls. Eotaxin and eotaxin-2 produced a dose- and time-dependent local eosinophilia of comparable intensity in both atopic and nonatopic individuals. This was associated with an acute wheal and flare response at the site of injection and development of a cutaneous late phase reaction in a proportion of subjects. There was an accompanying decrease in mast cell numbers. Both chemokines also induced the accumulation of basophils and an unexpected early infiltration of neutrophils. Macrophages were prominent at the 24-h point. Although there was surface CCR3 expression on neutrophils in whole blood, we were unable to demonstrate any functional neutrophil responses to eotaxin in vitro. Thus, intradermal injection of eotaxin and eotaxin-2 in humans induced infiltration of eosinophils and other inflammatory cells as well as changes consistent with CC chemokine-induced mast cell degranulation.
This article has been cited by other articles:
![]() |
N. J. Stevenson, M. R. Addley, E. J. Ryan, C. R. Boyd, H. P. Carroll, V. Paunovic, C. A. Bursill, H. C. Miller, K. M. Channon, A. E. McClurg, et al. CCL11 blocks IL-4 and GM-CSF signaling in hematopoietic cells and hinders dendritic cell differentiation via suppressor of cytokine signaling expression J. Leukoc. Biol., February 1, 2009; 85(2): 289 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Komatsu, D. Miyazaki, T. Tominaga, C.-H. Kuo, S. Namba, S. Takeda, H. Higashi, and Y. Inoue Transcriptional Analyses before and after Suppression of Immediate Hypersensitivity Reactions by CCR3 Blockade in Eyes with Experimental Allergic Conjunctivitis Invest. Ophthalmol. Vis. Sci., December 1, 2008; 49(12): 5307 - 5313. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Haley, M. E. Sunday, Y. Porrata, C. Kelley, A. Twomey, A. Shahsafaei, B. Galper, L. A. Sonna, and C. M. Lilly Ontogeny of the eotaxins in human lung Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L214 - L224. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Cheadle, K. Riyad, D. Subar, D. G. Rothwell, G. Ashton, H. Batha, D. J. Sherlock, R. E. Hawkins, and D. E. Gilham Eotaxin-2 and Colorectal Cancer: A Potential Target for Immune Therapy Clin. Cancer Res., October 1, 2007; 13(19): 5719 - 5728. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Farahi, A. S. Cowburn, P. D. Upton, J. Deighton, A. Sobolewski, E. Gherardi, N. W. Morrell, and E. R. Chilvers Eotaxin-1/CC Chemokine Ligand 11: A Novel Eosinophil Survival Factor Secreted by Human Pulmonary Artery Endothelial Cells J. Immunol., July 15, 2007; 179(2): 1264 - 1273. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Ochkur, E. A. Jacobsen, C. A. Protheroe, T. L. Biechele, R. S. Pero, M. P. McGarry, H. Wang, K. R. O'Neill, D. C. Colbert, T. V. Colby, et al. Coexpression of IL-5 and Eotaxin-2 in Mice Creates an Eosinophil-Dependent Model of Respiratory Inflammation with Characteristics of Severe Asthma J. Immunol., June 15, 2007; 178(12): 7879 - 7889. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.A. Silva, G.P. Garlet, S.Y. Fukada, J.S. Silva, and F.Q. Cunha Chemokines in Oral Inflammatory Diseases: Apical Periodontitis and Periodontal Disease Journal of Dental Research, April 1, 2007; 86(4): 306 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Main, R. Handy, J. Wilton, S. Smith, L. Williams, L. D. Fou, J. Andrews, L. A. Conroy, R. May, I. Anderson, et al. A Potent Human Anti-Eotaxin1 Antibody, CAT-213: Isolation by Phage Display and in Vitro and in Vivo Efficacy J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1395 - 1404. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Chan, J. K. Burgess, J. C. Ratoff, B. J. O'Connor, A. Greenough, T. H. Lee, and S. J. Hirst Extracellular Matrix Regulates Enhanced Eotaxin Expression in Asthmatic Airway Smooth Muscle Cells Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 379 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Prescott, E. Forbes, Paul. S. Foster, Klaus. Matthaei, and S. P. Hogan Mechanistic analysis of experimental food allergen-induced cutaneous reactions. J. Leukoc. Biol., August 1, 2006; 80(2): 258 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Huaux, M. Gharaee-Kermani, T. Liu, V. Morel, B. McGarry, M. Ullenbruch, S. L. Kunkel, J. Wang, Z. Xing, and S. H. Phan Role of Eotaxin-1 (CCL11) and CC Chemokine Receptor 3 (CCR3) in Bleomycin-Induced Lung Injury and Fibrosis Am. J. Pathol., December 1, 2005; 167(6): 1485 - 1496. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. O. Abonyo, M. S. Alexander, and A. S. Heiman Autoregulation of CCL26 synthesis and secretion in A549 cells: a possible mechanism by which alveolar epithelial cells modulate airway inflammation Am J Physiol Lung Cell Mol Physiol, September 1, 2005; 289(3): L478 - L488. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. de Paulis, N. Montuori, N. Prevete, I. Fiorentino, F. W. Rossi, V. Visconte, G. Rossi, G. Marone, and P. Ragno Urokinase Induces Basophil Chemotaxis through a Urokinase Receptor Epitope That Is an Endogenous Ligand for Formyl Peptide Receptor-Like 1 and -Like 2 J. Immunol., November 1, 2004; 173(9): 5739 - 5748. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Samoszuk, T. Deng, M. J. Hamamura, M.-Y. Su, N. Asbrock, and O. Nalcioglu Increased Blood Clotting, Microvascular Density, and Inflammation in Eotaxin-Secreting Tumors Implanted into Mice Am. J. Pathol., August 1, 2004; 165(2): 449 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Bumbacea, J Scheerens, B S Mann, R G Stirling, and K F Chung Failure of sputum eosinophilia after eotaxin inhalation in asthma Thorax, May 1, 2004; 59(5): 372 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Jaruga, F. Hong, R. Sun, S. Radaeva, and B. Gao Crucial Role of IL-4/STAT6 in T Cell-Mediated Hepatitis: Up-Regulating Eotaxins and IL-5 and Recruiting Leukocytes J. Immunol., September 15, 2003; 171(6): 3233 - 3244. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Phillips, V. E. L. Stubbs, M. R. Henson, T. J. Williams, J. E. Pease, and I. Sabroe Variations in Eosinophil Chemokine Responses: An Investigation of CCR1 and CCR3 Function, Expression in Atopy, and Identification of a Functional CCR1 Promoter J. Immunol., June 15, 2003; 170(12): 6190 - 6201. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Forsythe and A. D. Befus CCR3: A Key to Mast Cell Phenotypic and Functional Diversity? Am. J. Respir. Cell Mol. Biol., April 1, 2003; 28(4): 405 - 409. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |